Search the courses, subjects, tracks, games and features, or jump straight to a page.
Learn it your way
A short class with Sarah and her students. The other ways are under More.
Sign up free to listen. Transcripts are free to read.
Today we’re discussing gene therapy. Can anyone tell me what gene therapy is?
Isn’t it about changing genes to treat diseases?
Exactly! Gene therapy involves introducing, altering, or removing genes within a person's cells. It has two main types: somatic gene therapy, which targets non-reproductive cells, and germline gene therapy, which targets egg or sperm cells.
Why is germline therapy controversial?
Great question! Germline gene therapy raises ethical concerns and is often banned because changes affect future generations. Let’s remember: 'Somatic for Treatment, Germline for Debate'.
Can you give an example of somatic gene therapy?
Sure! A notable example is treating severe combined immunodeficiency, or SCID, by correcting immune genes. This shows how gene therapy can potentially save lives.
So we change the genes to fix diseases?
Exactly! To summarize, gene therapy can directly target genetic issues to treat conditions.
Now, let’s shift to the production of therapeutic proteins. Who can tell me what these proteins are?
Are they proteins made to treat different diseases?
Exactly! Genetically engineered organisms produce these proteins to manage diseases. For instance, insulin is produced in modified bacteria, primarily E. coli.
Why is genetic produced insulin preferred over the animal version?
Good question! Recombinant insulin is safer and more efficient, reducing the risk of allergic reactions. Let’s remember: 'Genes Fix, Proteins Treat'.
What other proteins are produced this way?
Other examples include human growth hormone for growth disorders and interferons for viral infections and cancer treatments. By genetically modifying organisms, we create numerous therapeutic solutions!
So we can make medicine from tiny microbes?
Yes! It’s fascinating how genetic engineering revolutionizes medical production. In summary, therapeutic proteins from engineered organisms are crucial for modern medicine.
To fight disease, we change our genes, from somatic cells to what later beams.
Imagine tiny surgeons going into cells, fixing problems directly and ringing healing bells!
Remember 'SGT' for gene therapy: S for Somatic, G for Germline, T for Treatment.
Use 'PRIME' for therapeutic proteins: P for Production, R for Recombinant, I for Insulin, M for Management of diseases, E for Efficiency.
Term
What is gene therapy?
Click to flip
Term
What is recombinant insulin?
Click to flip
Term
What are the types of gene therapy?
Click to flip
A technique that modifies a person’s genes to treat or prevent disease.
Gene therapy that targets non-reproductive cells.
Gene therapy that targets reproductive cells, often controversial.
Human insulin produced using genetic engineering, particularly in E. coli.
Proteins engineered to treat diseases, such as insulin and growth hormones.
Genetic engineering has transformed medical practices, particularly through gene therapy and the production of therapeutic proteins.
This section delves into gene therapy—targeting non-reproductive and reproductive cells to treat diseases—and the production of therapeutic proteins, like insulin and growth hormones, using genetically engineered organisms for more effective disease management.
In this section, we explore the critical applications of genetic engineering in medicine, focusing on two primary areas: gene therapy and the production of therapeutic proteins. Gene therapy involves the manipulation of genes within a person's cells to treat or prevent disease, distinguished into somatic gene therapy, which targets non-reproductive cells, and germline gene therapy, which focuses on reproductive cells but raises ethical concerns. For example, somatic gene therapy has been used successfully to treat severe combined immunodeficiency (SCID) by correcting immune genes. The section also highlights the role of genetically engineered organisms in producing vital therapeutic proteins. These include human insulin for diabetes management, growth hormones for treating growth disorders, and interferons for addressing viral infections and cancer therapy. Recombinant insulin produced in modified E. coli serves as a prime example, showcasing its safety and efficiency compared to animal-derived insulin. Both gene therapy and therapeutic protein production underscore the profound impact of genetic engineering on modern medicine, leading to innovative treatments and improved health outcomes.